Inhibiting pyruvate kinase muscle isoform 2 regresses group 2 pulmonary hypertension induced by supra‐coronary aortic banding-Reference-Cited by-同舟云学术

Inhibiting pyruvate kinase muscle isoform 2 regresses group 2 pulmonary hypertension induced by supra‐coronary aortic banding

Published:2022-01-17 Issue:2 Volume:234 Page:
ISSN:1748-1708
Container-title:Acta Physiologica
language:en
Short-container-title:Acta Physiologica

Author:

Xiong Ping Yu¹²^ORCID,Motamed Mehras¹,Chen Kuang‐Hueih¹,Dasgupta Asish¹,Potus François¹,Tian Lian¹^ORCID,Martin Ashley¹,Mewburn Jeffrey¹,Jones Oliver¹,Thébaud Arthur¹,Archer Stephen L.¹²^ORCID

Affiliation:

1. Department of Medicine Queen’s University Kingston Ontario Canada

2. Queen's Cardiopulmonary Unit (QCPU) Kingston Ontario Canada

Funder

Foundation for the National Institutes of Health

Canada Foundation for Innovation

Canadian Institutes of Health Research

Canada Research Chairs

Publisher

Wiley

Subject

Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apha.13764

Reference24 articles.

1. Evaluation of the impact of an echocardiographic diagnosis of pulmonary hypertension on patient outcomes;Xiong PY;Can J Cardiol Open,2020

2. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

3. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: Analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database

4. Clinical Characteristics of Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction

5. Increasing incidence and prevalence of World Health Organization groups 1 to 4 pulmonary hypertension—a population‐based cohort study in Ontario, Canada;Wijeratne DT;Circulation,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compound 3K attenuates isoproterenol-induced cardiac hypertrophy by inhibiting pyruvate kinase M2 (PKM2) pathway;Life Sciences;2024-08

2. Pyruvate Kinase M2: A Potential Regulator of Cardiac Injury Through Glycolytic and Non-glycolytic Pathways;Journal of Cardiovascular Pharmacology;2024-03-29

3. The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches;Basic Research in Cardiology;2023-11-08

4. Translation: Bench to bedside—And back;Acta Physiologica;2023-04-04

5. An update on hypertension;Acta Physiologica;2023-02-05